St. Louis, Missouri – January 22, 2008 – Partek Incorporated and Quimica Valaner have announced a distribution agreement under which Valaner will provide sales and marketing in Mexico for each of Partek’s software solutions. Partek’s software solutions include Partek^® Genomics Suite^TM, Partek^® Discovery Suite^TM, Partek^® QSAR Solution^TM, and Partek^® Screener’s Solution^TM, with each package integrating powerful statistical analysis with interactive data visualization, designed to target specific research areas in the life sciences market.

"Uniscience has a proven track record of meeting the needs of their customers with essential technology and software solutions. We look forward to this partnership, as we work together to provide powerful analysis software backed by outstanding customer support to the scientific communities throughout Brazil," said Tom Downey, President of Partek Inc.

Researchers at MGH will use Partek to detect copy number variation in family research. MHG, the third oldest hospital in the United States, is dedicated to research that improves the lives of their patients. MHG is located in Boston.

Researchers at NIBR will use Partek GS to analyze genomic data. NIBR, Novartis’ research organization, is dedicated to finding new treatments for areas within dermatology, oncology, and immunology. Headquartered in Cambridge, Massachusetts, NIBR has sites all over the world including in Basel, Switzerland; Vienna, Austria; Horsham, UK; Tsukuba, Japan, Shanghai, China; and East Hanover, New Jersey.

Scientists at HRI will use Partek to analyze gene expression data generated from studies about the effects of sex hormones in heart disease and the link between diabetic kidney disease and heart disease. HRI is Australia’s leading institute for atherosclerosis research and was founded in 1989. HRI is located in New South Wales.

Researchers at INSERM and the University of Nantes will use Partek GS to analyze data from expression and genotyping studies on tumor cells. The INSERM, established in 1964, is a public scientific organization that is dedicated to promoting health and well being of all citizens. The University of Nantes is located in Nantes, France.

The Health Sciences Center at KU will use Partek GS for a variety of applications. Kuwait University, located in Kuwait City. Partek GS allows for thorough analysis of gene expression, exon alternative splicing, copy number, genome-wide SNP, and ChIP-chip regulation data within in the same software package. In addition, Partek GS provides easy to use workflows to walk through the analysis process. Partek GS is Affymetrix GeneChip-compatible^TM for gene expression analysis, exon expression analysis, chromosomal copy number analysis, tiling array analysis, and chromosomal copy number analysis of high density SNP arrays.

Erasmus MC has recently expanded the number of Partek licenses in use at the facility. Located in Rotterdam, The Netherlands, Erasmus MC is a first class research hospital that also includes the Erasmus MC – Sophia hospital for children and the Erasmus MC – Daniel den Hoed Cancer Center.

Researchers at Roche Molecular Diagnostics will use Partek GS to analyze diagnostic data from a variety of studies involving drug development. Current research at Roche involves using biomarkers to determine patients’ reactions to specific medications, as well as drug discovery. Roche, a leader in the pharmaceutical industry, has provided such therapeutic drugs as Tamiflu^®, Herceptin^®, and Boniva^®.

Cardiff University, located in Wales, was founded in 1883. Partek GS allows for thorough analysis of gene expression, exon alternative splicing, copy number, genome-wide SNP, and ChIP-chip regulation data within in the same software package. In addition, Partek GS provides easy to use workflows to walk through the analysis process. Partek GS is Affymetrix GeneChip-compatible^TM for gene expression analysis, exon expression analysis, chromosomal copy number analysis, tiling array analysis, and chromosomal copy number analysis of high density SNP arrays.